Cangene Corporation · Winnipeg, MB Canada · (Toronto: CNJ)
Company Description
View Cangene Corporation Locations On A US Map
This link will open in a new window
This link will open in a new window Cangene is hyper about hyperimmunes. The company makes plasma products known as hyperimmunes, which are antibody preparations and recombinant biopharmaceuticals made by introducing a gene in a host organism. Cangene's drugs are used to treat plasma-derived disorders, including the blood clotting disorder thrombocytopenic purpura and hemolytic disease of the newborn, which occurs when a fetus' blood type is incompatible with its mother's. Cangene has several approved products and is developing others, mainly in the areas of infectious disease and biodefense. Generic giant Apotex owns more than 80% of Cangene. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Cangene Corporation Reports
No subscription, no problem.
Download presentation-ready reports for this company now.
Download presentation-ready reports for this company now.
From company profiles to the competitive landscape, Hoover’s offers immediate access to individual reports.
Key Cangene Corporation Financials
| Company Type | Public - Toronto: CNJ Headquarters |
| Fiscal Year-End | July |
| Employees | 682 |
Cangene Corporation Executives
22 executives listed for Cangene Corporation's Winnipeg, MB location.
| Title | Name & Bio | Contact |
| Chairman | Jacob Kay | |
| President, CEO, and Director | John Langstaff | |
| SVP Operations | William Bees |
Competition
Competitive Landscape for Cangene Corporation
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Cangene Corporation Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!